Clinical implications of the JAK2 V617F mutation in essential thrombocythemia

被引：190
|
作者：
Antonioli, E [1 ]
Guglielmelli, P [1 ]
Pancrazzi, A [1 ]
Bogani, C [1 ]
Verrucci, M [1 ]
Ponziani, V [1 ]
Longo, G [1 ]
Bosi, A [1 ]
Vannucchi, AM [1 ]
机构：
[1] Univ Florence, Dept Hematol, Azienda Osped, I-50134 Florence, Italy
来源：
LEUKEMIA | 2005年 / 19卷 / 10期
关键词：
D O I：
10.1038/sj.leu.2403902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1847 / 1849
页数：4
相关论文
共 50 条
  • [1] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
    E Antonioli
    P Guglielmelli
    A Pancrazzi
    C Bogani
    M Verrucci
    V Ponziani
    G Longo
    A Bosi
    A M Vannucchi
    Leukemia, 2005, 19 : 1847 - 1849
  • [2] The JAK2 V617F mutation in essential thrombocythemia
    Cho, Young-Uk
    Chung, Hee-Jung
    Chi, Hyun-Sook
    Jang, Seoungsoo
    Park, Chan-Jeoung
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 103 - 103
  • [3] JAK2 V617F mutation in essential thrombocythemia.
    Ahn, Jeong Yeal
    Park, Pil Whan
    Seo, Yiel Hea
    Shin, Dong-Bok
    Lee, Jae-Hoon
    Yoo, Soo-Jin
    Bang, Soo-Mee
    BLOOD, 2006, 108 (11) : 318B - 318B
  • [4] Assessment of JAK2 V617F mutation in Tunisian patients with essential thrombocythemia
    Belhiba, M.
    Bellaaj, H.
    Keskes, L.
    Frikha, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1016 - 1016
  • [5] 2 DIFFERENT PHENOTYPES IN ESSENTIAL THROMBOCYTHEMIA: MUTATION JAK2 V617F OR CALR
    Vilches Moreno, A. S.
    Guerrero Fernandez, L.
    Latorre Gonzalez, A.
    Monteagudo Saiz, D.
    Robles Marina, V
    Andreu Costa, A.
    Ayala Diaz, R.
    Martinez Lopez, J.
    HAEMATOLOGICA, 2016, 101 : 187 - 187
  • [6] JAK2 V617F mutation to calreticulin mutation in an essential thrombocythemia patient: A case report
    Wang, Su-Yun
    Yang, Ning
    Zhang, Li-Jun
    Cheng, Zhi-Yong
    INDIAN JOURNAL OF CANCER, 2021, 58 (03) : 431 - 433
  • [7] ESSENTIAL THROMBOCYTHEMIA WITH JAK2 V617F OR CALR MUTATION: TWO DIFFERENT PHENOTYPES
    Vilches Moreno, A. S.
    Guerrero Fernandez, L.
    Gonzalez Medina, J.
    Ayala Diaz, R.
    Martinez Lopez, J.
    Monteagudo Saiz, D.
    Andreu Costa, M. A.
    Robles Marinas, V.
    HAEMATOLOGICA, 2016, 101 : 811 - 811
  • [8] IMPACT OF JAK2 V617F MUTATION ON CLINICAL OUTCOME OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: A RETROSPECTIVE STUDY
    Wojcik, M.
    Renc, M.
    Skotnicki, A. B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 507 - 507
  • [9] Frequency and Clinical Features of the JAK2 V617F Mutation in Pediatric Patients With Sporadic Essential Thrombocythemia
    Nakatani, Takuya
    Imamura, Toshihiko
    Ishida, Hiroyuki
    Wakaizumi, Katsuji
    Yamamoto, Tohru
    Otabe, Osamu
    Ishigami, Tsuyoshi
    Adachi, Souichi
    Morimoto, Akira
    PEDIATRIC BLOOD & CANCER, 2008, 51 (06) : 802 - 805
  • [10] Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome
    Briere, Jean
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2007, 191 (03): : 535 - 548
12345